SCHEMBL7329131

SCHEMBL7329131

CCOC(=O)C(CCc1c[nH]c2ccccc12)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O

nearest known ligand 0.72

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 13/20 0.72
▸ LMNA P02545 2/20 0.72
▸ SMN1; SMN2 Q16637 1/20 0.67
▸ ABCB11 O95342 2/20 0.51
▸ MEN1 O00255 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ USP2 O75604 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ CYP2C19 P33261 1/20 0.49
▸ PDE3A Q14432 1/20 0.47
▸ BCHE P06276 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329431 0.92 ACE (0.65) ACELMNASMN1; SMN2ABCB11CYP2C19
SCHEMBL7321737 0.91 ACE (0.70) ACELMNASMN1; SMN2CYP2C19BCHE
SCHEMBL11262324 0.90 ACE (0.57) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL11258648 0.89 ACE (0.56) ACELMNASMN1; SMN2CYP3A4CYP2C19
SCHEMBL683545 0.87 ACE (0.60) ACELMNASMN1; SMN2CYP2C19BCHE
SCHEMBL7324321 0.85 ACE (0.55) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL7324326 0.85 ACE (0.55) ACELMNASMN1; SMN2MEN1KMT2A
SCHEMBL7325826 0.84 ACE (0.61) ACELMNASMN1; SMN2ALOX15CYP2C19
SCHEMBL7325822 0.84 ACE (0.61) ACELMNASMN1; SMN2ALOX15CYP2C19
Enalapril SCHEMBL8089096 0.84 ACE (1.00) ACELMNASMN1; SMN2ABCB11MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4472380-A CARBOXYALKYL DIPEPTIDE DERIVATIVES MERCK & CO., INC. (US) 1984-09-18 — — US disclosed
US-4374829-A Aminoacid derivatives as antihypertensives MERCK & CO., INC. (US) 1983-02-22 — — US disclosed
Send feedback